Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?
Senator Josh Hawley wants Congress to revoke the FDA's approval of mifepristone and ban the abortion pill nationally. His bill has stalled in committee, and in September he began pressing Republicans to sign a pledge backing it.
Case period:
Published by The Dispute Index editorial teamPublished Updated
Overview
On March 11, 2026, Senator Josh Hawley introduced the Safeguarding Women from Chemical Abortion Act, which would withdraw the Food and Drug Administration's approval of mifepristone for pregnancy termination, make distributing and labeling the drug for that purpose violations of the Federal Food, Drug and Cosmetic Act, and let women who say chemical abortion harmed them sue its manufacturers. Mifepristone has been approved in the United States since 2000 and is used in a large majority of American abortions. Hawley argues a national ban is the only remedy because the drug can be mailed into states whose own laws restrict abortion. The bill drew seven Republican cosponsors but has not moved out of the Senate Health, Education, Labor and Pensions Committee. On September 16, 2026, Hawley unveiled a four-page "Declaration for Life" and began asking officeholders and candidates to sign it as a commitment to ban the drug. The dispute is over whether Congress should enact that ban.
Read the full background
This case classifies responses to Hawley's proposition that Congress should ban mifepristone by revoking its federal approval. Responses are recorded against that proposition, not against abortion generally and not against the separate question of whether the Trump administration should act through the FDA.
The bill is S. 4066 (opens in a new tab), introduced March 11, 2026 and referred to the Senate Health, Education, Labor and Pensions Committee, where it remains. Its seven Republican cosponsors joined on staggered dates: John Cornyn (March 12), Marsha Blackburn (March 18), Ted Budd (March 23), Tommy Tuberville (March 25), Bernie Moreno (April 15), James Lankford (April 20) and Mike Rounds (June 23). None has withdrawn, and none has joined since June. The identical House companion, H.R. 7902, was introduced by Diana Harshbarger on March 12, 2026 and is likewise unmoved. Cosponsorship is a legislative act rather than a public statement; of the seven, only Cornyn has made an attributed public comment, which is recorded separately.
Hawley's central safety claim, that roughly one in ten women suffer serious complications, rests on a 2025 paper from the Ethics and Public Policy Center. PolitiFact (opens in a new tab) reported that the paper was not peer reviewed, did not disclose its data source, and was criticised by more than 250 reproductive health researchers; recategorised under the FDA's own definitions the same data yields rates of 0.10 percent for sepsis, 0.15 percent for blood transfusion and 0.22 percent for life-threatening events. The FDA has said it has identified no new safety concerns with the drug. We record this because both sides argue from it, not to settle the dispute.
Susan Collins and Lisa Murkowski were the only Republican senators who declined to sign a letter to the Department of Health and Human Services calling for a mifepristone crackdown, and their spokespeople did not answer questions about this bill. Non-response is not a position and no record is created for it.
People in this case
Josh HawleyDirectly involved
John CornynDirectly involved
Marsha BlackburnDirectly involved
Ted BuddDirectly involved
Timeline
4 timeline entries on this page. Dates: March 11, 2026 to September 16, 2026
March 2026
Hawley introduces the Safeguarding Women from Chemical Abortion Act
Incident
Senator Josh Hawley introduced S. 4066, the Safeguarding Women from Chemical Abortion Act, and announced it at a Capitol Hill press conference with anti-abortion movement leaders. The bill would withdraw the Food and Drug Administration's approval of mifepristone for pregnancy termination, make distributing and labeling the drug for that purpose violations of the Federal Food, Drug and Cosmetic Act, and create a private right of action for women who say chemical abortion harmed them to sue manufacturers. It was referred to the Senate Committee on Health, Education, Labor and Pensions. An identical House companion, H.R. 7902, was introduced by Representative Diana Harshbarger the following day.
[01]United States Congress
The bill at issue in this case. It would withdraw the Food and Drug Administration's approval of mifepristone for pregnancy termination, make distributing and labeling the drug for that purpose violations of the Federal Food, Drug and Cosmetic Act, and create a private right of action for women who say chemical abortion harmed them to sue manufacturers. Legislative status and the cosponsor roster were verified against the GovTrack published record (bill 428713) on September 18, 2026, because congress.gov blocked access: seven Republican cosponsors, none withdrawn, the most recent joining June 23, 2026, and no action beyond committee referral. The identical House companion is H.R. 7902, introduced by Rep. Diana Harshbarger on March 12, 2026.
S. 4066 — Safeguarding Women from Chemical Abortion Act, 119th Congress · United States CongressS. 4066, 119th Congress, 2nd Session. Sponsor: Sen. Josh Hawley. Introduced March 11, 2026; referred to the Senate Committee on Health, Education, Labor and Pensions.[02]Josh Hawley
Source excerpt
The science is clear: the chemical abortion drug is inherently dangerous to women and prone to abuse.
Hawley's own announcement of the bill, issued alongside a Capitol Hill press conference with anti-abortion movement leaders. It states the bill's three operative provisions and carries the quotation on which his safety claim rests.
Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders · Josh HawleyOfficial Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.Harshbarger introduces the House companion bill
Diana Harshbarger introduced H.R. 7902, the House companion proposing to withdraw mifepristone's approval for pregnancy termination and create a federal damages claim.
[03]H.R. 7902 as introduced in the House
Diana Harshbarger introduced H.R. 7902, the House companion proposing to withdraw mifepristone's approval for pregnancy termination and create a federal damages claim.
H.R. 7902 as introduced in the HouseOfficial introduced bill, header and sections 2-3
June 2026
Seven Republican senators cosponsor the bill over three months, then recruitment stops
Incident
Seven Republican senators signed on as cosponsors of S. 4066 on staggered dates: John Cornyn on March 12, Marsha Blackburn on March 18, Ted Budd on March 23, Tommy Tuberville on March 25, Bernie Moreno on April 15, James Lankford on April 20 and Mike Rounds on June 23. None subsequently withdrew, and no further senator joined after that date. The bill received no committee action. Cosponsorship is a legislative act rather than a public statement, and of the seven only Cornyn has made an attributed public comment on the bill.
[01]United States Congress
The bill at issue in this case. It would withdraw the Food and Drug Administration's approval of mifepristone for pregnancy termination, make distributing and labeling the drug for that purpose violations of the Federal Food, Drug and Cosmetic Act, and create a private right of action for women who say chemical abortion harmed them to sue manufacturers. Legislative status and the cosponsor roster were verified against the GovTrack published record (bill 428713) on September 18, 2026, because congress.gov blocked access: seven Republican cosponsors, none withdrawn, the most recent joining June 23, 2026, and no action beyond committee referral. The identical House companion is H.R. 7902, introduced by Rep. Diana Harshbarger on March 12, 2026.
S. 4066 — Safeguarding Women from Chemical Abortion Act, 119th Congress · United States CongressS. 4066, 119th Congress, 2nd Session. Sponsor: Sen. Josh Hawley. Introduced March 11, 2026; referred to the Senate Committee on Health, Education, Labor and Pensions.
September 2026
Hawley unveils a "Declaration for Life" pledge and asks candidates to sign it
Incident
At the close of the first Missouri Prayer Breakfast, held in the Kennedy Caucus Room of the Russell Senate Office Building, Hawley unveiled a four-page "Declaration for Life" drafted by more than 30 pastors and signed by more than 100 Missouri pastors and about 50,000 citizens. The document calls on Congress to ban mifepristone, arguing that state abortion restrictions are insufficient because the drug can be mailed across state lines. Hawley said he would ask officeholders and candidates in both parties to sign it. Tony Perkins of the Family Research Council and the Christian musician Sean Feucht joined him at the unveiling. Reporting at the time noted the bill had not received much discussion within the Senate Republican conference since its introduction.
[04]Josh Hawley
Source excerpt
This Declaration for Life, written by pastors, is calling on everyday Christians across America to stand for life and confront the scourge of chemical abortion.
The primary record of the Declaration for Life, the pledge Hawley is asking officeholders and candidates to sign. The declaration states that the abortion drug is "nearly always fatal to the unborn child and frequently injurious to the mother," that mifepristone "can now be mailed into every state and city in America, regardless of local rules," and calls on Congress "to ban the chemical abortion drug mifepristone."
Hawley Unveils Declaration for Life with Christian Leaders · Josh HawleyOfficial Senate office press release following the first Missouri Prayer Breakfast, held September 16, 2026, in the Kennedy Caucus Room of the Russell Senate Office Building. Includes the text of the four-page Declaration for Life.[05]The Hill
Source excerpt
Hawley's mifepristone bill has at least seven Republican co-sponsors but hasn't received much discussion within the Senate GOP conference since he introduced it.
Contemporaneous reporting on the September 16 event, naming Tony Perkins of the Family Research Council and the Christian musician Sean Feucht as joining Hawley at the unveiling, and recording Hawley's request that candidates in both parties sign the pledge. The same quotations appear in the syndicated version carried by Yahoo News.
Hawley to push GOP officeholders, candidates to sign 'Declaration for Life' · The HillThe Hill, September 16, 2026, 12:15 PM ET. Report on the Declaration for Life unveiling.
Claims
Claims separate what was said from what is contested. Follow each source for the original wording and context.
What's disputed
Disputed claim
The science is clear that the chemical abortion drug is inherently dangerous to women and prone to abuse.
Sources (2)
- Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders · Josh HawleyOfficial Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.
- S. 4066 — Safeguarding Women from Chemical Abortion Act, 119th Congress · United States CongressS. 4066, 119th Congress, 2nd Session. Sponsor: Sen. Josh Hawley. Introduced March 11, 2026; referred to the Senate Committee on Health, Education, Labor and Pensions.
Disputed claim
The science is clear that mifepristone is safe, is effective, and remains medically indicated.
Sources (1)
- Senate Introduces Attack on Mifepristone · Physicians for Reproductive HealthOrganizational press release, March 12, 2026, carrying a statement attributed to president and chief executive Dr. Jamila Perritt.
Disputed claim
A national ban is the only effective remedy, because mifepristone can be mailed into states whose own laws restrict abortion.
Sources (1)
- S. 4066 — Safeguarding Women from Chemical Abortion Act, 119th Congress · United States CongressS. 4066, 119th Congress, 2nd Session. Sponsor: Sen. Josh Hawley. Introduced March 11, 2026; referred to the Senate Committee on Health, Education, Labor and Pensions.
Disputed claim
Hawley’s own Missouri constituents voted to protect abortion access.
Sources (1)
- Reproductive Freedom for All Condemns Senator Hawley's Bill To Revoke FDA Approval of Mifepristone · Reproductive Freedom for AllOrganizational press release, March 12, 2026, carrying a statement attributed to president and chief executive Mini Timmaraju.
Disputed claim
The timing of the bill is not about a political cycle but about protecting the health and safety of women and the unborn.
Sources (1)
- Hawley's abortion pill move puts Republican senators in a bind · AxiosAxios, March 19, 2026. Report on Senate Republican reaction to the Safeguarding Women from Chemical Abortion Act.
Show fewer disputed claims
Disputed claim
The Republican Party has lost its voice on abortion, leaving a vacuum that Hawley is stepping forward to fill.
Sources (1)
- Hawley to push GOP officeholders, candidates to sign 'Declaration for Life' · The HillThe Hill, September 16, 2026, 12:15 PM ET. Report on the Declaration for Life unveiling.
Response record
Responses
Choose one response filter, or select All responses to see the full record.
9 matching responses. First 6 shown initially. Newest first.
Josh HawleyUnited States senator from MissouriDirectly involvedBefore this statement
In an interview after Overton's Senate HELP Committee hearing, Hawley said he wanted the FDA under her leadership to end abortion-drug availability in Missouri and every other state.
"We've got to make sure that she is committed to ending the abortion drugs' availability in the state of Missouri and every other state. That they're going to put back in place the safety restrictions and they're going to follow the law."
Defended or excusedCase context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?
Full statement and sources
After a Senate hearing for FDA commissioner nominee Heidi Overton, Hawley urged the FDA under her leadership to end abortion-drug availability in Missouri and every other state and restore safety restrictions.
After the statement
Politico and Fierce Biotech separately reported that Hawley challenged Overton during the hearing over mifepristone regulation and its labeling.
EXCLUSIVE: Sen. Hawley says FDA commissioner nominee denied dangers of chemical abortion; demands answers amid lawsuits, official reviewParagraphs beginning "What I want to be real sure about" and "We've got to make sure."Overton skirts senators' questions on abortion pill · PoliticoParagraph beginning "Missouri Republican Josh Hawley" and the article's report of the Senate HELP Committee hearing.Trump's FDA pick Heidi Overton calls vaccines, mifepristone safe and effective in confirmation hearingParagraphs beginning "Senator Josh Hawley" and "In court, Hawley said."Why this label?
This statement concerns potential FDA action and does not by itself establish Hawley's position on congressional enactment.
This label describes the statement's response within the context above.
- Josh HawleyUnited States Senator for Missouri, at the first Missouri Prayer Breakfast in the Russell Senate Office Building and in a subsequent official press releaseDirectly involved
Before this statement
S. 4066 had drawn no new cosponsor since June 23 and had received no committee action. Reporting at the time noted the bill had not been much discussed within the Senate Republican conference.
"This Declaration for Life, written by pastors, is calling on everyday Christians across America to stand for life and confront the scourge of chemical abortion."
Defended or excusedCase context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?
Full statement and sources
Six months after his bill stalled in committee, Hawley unveiled a four-page "Declaration for Life" drafted by more than 30 pastors, which calls on Congress to ban mifepristone on the grounds that state abortion restrictions cannot stop the drug being mailed across state lines. He said he would ask officeholders and candidates in both parties to sign it as a commitment to end chemical abortion, and renewed his request for a vote on his legislation.
After the statement
Tony Perkins of the Family Research Council said anti-abortion groups would circulate the declaration as a standard for candidates. The pledge is modelled on the Taxpayer Protection Pledge used to bind Republicans against tax increases.
Hawley Unveils Declaration for Life with Christian Leaders · Josh HawleyOfficial Senate office press release following the first Missouri Prayer Breakfast, held September 16, 2026, in the Kennedy Caucus Room of the Russell Senate Office Building. Includes the text of the four-page Declaration for Life.Hawley to push GOP officeholders, candidates to sign 'Declaration for Life' · The HillThe Hill, September 16, 2026, 12:15 PM ET. Report on the Declaration for Life unveiling.Why this label?
Here he not only restates the proposition but attaches a loyalty mechanism to it, asking candidates to pledge support for the ban. The closest competing label is “Mixed or conditional”, because the statement is addressed to Christians and churches rather than to legislators and could be read as a cultural appeal rather than a legislative demand. That loses because the declaration's own operative request is that Congress ban the drug, and Hawley paired the unveiling with a renewed call for a vote on his bill.
This label describes the statement's response within the context above.
Tommy TubervilleUnited States Senator for Alabama, in an official press release announcing that he joined Hawley's billDirectly involvedBefore this statement
Hawley introduced the Safeguarding Women from Chemical Abortion Act on March 11, 2026. Tuberville's release, dated March 26, said he had joined Hawley in introducing it.
"One in ten women who take this drug suffer serious health problems and it needs to be banned. These companies need to be put out of business and forced to pay the price for the damage they’ve caused. I’m proud to join this legislation with Sen. Hawley to ban mifepristone and empower the women who have been harmed to hold these pharmaceutical companies accountable."
Defended or excusedCase context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?
Full statement and sources
Senator Tommy Tuberville said one in ten women who take mifepristone suffer serious health problems and that the drug needs to be banned. He also said he was proud to join Hawley's bill, which would let harmed women sue the drug's manufacturers.
After the statement
The release listed the bill's provisions, including withdrawing the FDA's approval of mifepristone for abortion and creating a private right of action against manufacturers. Separately, PolitiFact reported on May 26, 2026 that Republican senators had cited a figure of 1 in 10 women experiencing serious complications, and that the figure comes from a report by a conservative nonprofit that was not published in a peer-reviewed medical journal and that more than 250 reproductive health researchers criticized. The PolitiFact article did not name Tuberville.
Tuberville Takes Action to Ban Dangerous Abortion Drug · Tommy TubervillePress release dated March 26, 2026, second paragraph (remarks attributed to Tuberville).Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders · Josh HawleyOfficial Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.Amid efforts to restrict mifepristone access, here’s what studies say about the medication · PolitiFactThird paragraph, on the one-in-ten complication figure.Why this label?
The reference point is Hawley's proposal that Congress ban mifepristone by withdrawing its federal approval. Tuberville said the drug needs to be banned and that he was proud to join Hawley's legislation to do it. That is direct support for the ban, so we labeled it Defended or excused.
This label describes the statement's response within the context above.
- Josh HawleyUnited States Senator for Missouri, responding to questions from AxiosDirectly involved
Before this statement
Axios reported that Hawley's push was elevating an issue many Republicans hoped to avoid before the midterms.
"This isn't about a political cycle, this is about protecting the health and safety of women, and also protecting the unborn."
Defended or excusedCase context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?
Full statement and sources
Asked by Axios about Republican unease that his bill would raise abortion before the midterm elections, Hawley said the measure was not driven by the electoral calendar but by protecting women's health and the unborn. He added that opposition to abortion is "a foundational issue for the Republican Party" and that anti-abortion voters are the party's most dependable.
After the statement
The same report recorded that Senator John Cornyn had endorsed the bill while Senators Thom Tillis and Jon Husted each said they had not seen it.
Hawley's abortion pill move puts Republican senators in a bind · AxiosAxios, March 19, 2026. Report on Senate Republican reaction to the Safeguarding Women from Chemical Abortion Act.Why this label?
He defends that proposition against the objection that it is electorally reckless, restating its justification rather than qualifying it. The closest competing label is “Mixed or conditional”, since he is responding to a political objection rather than making a fresh policy argument. That loses because he concedes nothing and attaches no condition; the remark reaffirms the ban on the same grounds he gave when introducing it.
This label describes the statement's response within the context above.
- Josh HawleyU.S. senator from MissouriDirectly involved
Before this statement
Josh Hawley's proposal would require withdrawal of mifepristone's approval for pregnancy termination. A House companion was introduced by Diana Harshbarger.
"Congress should ban mifepristone"
Defended or excusedCase context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?
Full statement and sources
Josh Hawley argued that restoring earlier FDA restrictions would be insufficient because later administrations could undo them.
After the statement
Hawley argued that later administrations could reverse FDA restrictions, making a legislative ban necessary.
Josh Hawley explains why Congress should ban mifepristoneFinal policy argumentWhy this label?
Josh Hawley argues for Hawley's mifepristone ban. Hawley argued that later administrations could reverse FDA restrictions, making a legislative ban necessary.
This label describes the statement's response within the context above.
Diana HarshbargerUnited States Representative for Tennessee's 1st District, in an official press release introducing the House companion billDirectly involvedBefore this statement
Hawley unveiled the Safeguarding Women from Chemical Abortion Act at a press conference on March 11, 2026, and his release said Harshbarger would introduce companion legislation in the House. That release carried a slightly different version of these remarks.
"As a pharmacist for decades prior to now serving in U.S. House of Representatives, I believe every drug approved in the United States must meet the highest standards of safety, transparency, and medical oversight Yet the FDA under previous administrations has steadily dismantled critical safeguards surrounding the abortion drug mifepristone — removing in-person dispensing requirements, allowing the drug to be shipped through the mail, and limiting adverse event reporting so the most serious complications are no longer tracked. Evidence now suggests that real world risks to women are greater than the federal government has acknowledged. That’s why I’m proud to join Senator Hawley to introduce the Safeguarding Women from Chemical Abortion Act that would restore accountability and help ensure that women’s health and safety — not politics — guide federal drug policy."
Defended or excusedCase context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?
Full statement and sources
Representative Diana Harshbarger said she was proud to join Senator Josh Hawley in introducing the Safeguarding Women from Chemical Abortion Act. She said that, as a pharmacist for decades, she believes every approved drug must meet the highest standards of safety and oversight, and that the FDA under earlier administrations had dismantled safeguards around mifepristone.
After the statement
Her release listed the bill's three provisions: withdrawing the FDA's approval of mifepristone for abortion, making its distribution and labeling for pregnancy termination violations of the Federal Food, Drug, and Cosmetic Act, and creating a private right of action for women harmed by chemical abortion to sue manufacturers. It named eight organizations as supporters, including Susan B. Anthony Pro-Life America and the Family Research Council.
Harshbarger, Hawley Introduce Bill to Ban Chemical Abortion Drug · Diana HarshbargerPress release dated March 12, 2026, second paragraph (remarks attributed to Harshbarger).Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders · Josh HawleyOfficial Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.Why this label?
The reference point is Hawley's proposal that Congress ban mifepristone by withdrawing its federal approval. Harshbarger introduced the House companion bill and said she was proud to join Hawley in doing so, arguing that the FDA had removed safeguards and that the bill would restore accountability. Introducing and endorsing the ban is a direct defense of the proposal, so we labeled it Defended or excused.
This label describes the statement's response within the context above.
Show fewer responses
Bill CassidyUnited States Senator for Louisiana and chairman of the Senate Committee on Health, Education, Labor and Pensions, responding to questions from MS NOWDirectly involvedBefore this statement
S. 4066 had been referred to Cassidy's committee the previous day. He had held a hearing in January on what he called the dangers of mifepristone and had joined an amicus brief on the drug's dispensing rules. He was facing a primary challenge.
"I haven't seen this particular legislation."
Explicitly stayed outCase context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?
Full statement and sources
Asked about Hawley's bill, Senator Bill Cassidy, chairman of the Senate Health, Education, Labor and Pensions Committee to which it had been referred, told MS NOW that he opposes the current scope of availability of abortion pills, then added that he had not seen this particular legislation. He has not said whether his committee will take the bill up.
After the statement
The bill has received no committee action in the six months since. A Cassidy spokesperson referred questions to the senator's past work on the issue.
Anti-abortion groups to GOP: Act on mifepristone or pay in the midterms · MS NOWMS NOW, March 13, 2026. Report on the Republican and anti-abortion movement response to the Hawley bill.Why this label?
Asked directly for his position on the bill, Cassidy closed the question by saying he had not seen it, while stating a general view on abortion pill availability. That is a refusal to take a position on the specific proposal. The closest competing label is “Defended or excused”, because he volunteered that he opposes the drug's current availability. That loses because this case is the congressional ban, not availability in the abstract; his general remark does not commit him to the bill, and the operative part of the answer withholds a position on it.
This label describes the statement's response within the context above.
John CornynUnited States Senator for Texas, posting on his own account on XDirectly involvedBefore this statement
Cornyn was in a difficult Republican primary in Texas when the bill was introduced. He was the first of seven Republicans to cosponsor it.
"All in"
Defended or excusedCase context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?
Full statement and sources
Senator John Cornyn posted "All in" on X the day after Hawley introduced the Safeguarding Women from Chemical Abortion Act, endorsing the bill. He formally joined as its first cosponsor the same day. Cornyn was facing a contested Republican primary in Texas at the time.
After the statement
Of the seven eventual Republican cosponsors, Cornyn is the only one to have made an attributed public statement about the bill.
Anti-abortion groups to GOP: Act on mifepristone or pay in the midterms · MS NOWMS NOW, March 13, 2026. Report on the Republican and anti-abortion movement response to the Hawley bill.Why this label?
Cornyn's two words are brief but unambiguous in their context: they were posted in direct response to the bill's introduction and accompanied by his cosponsorship the same day. The closest competing label is unclear, given the brevity of the post. That loses because the target and direction are fixed by the surrounding facts, and the accompanying legislative act removes any doubt about which position the words express.
This label describes the statement's response within the context above.
- Josh HawleyUnited States Senator for Missouri, in an official press release announcing his own legislationDirectly involved
Before this statement
Hawley had spent the previous year pressing the Food and Drug Administration to review mifepristone's safety and had grown frustrated with the pace of that review. He announced the bill at a Capitol Hill press conference alongside anti-abortion movement leaders.
"The science is clear: the chemical abortion drug is inherently dangerous to women and prone to abuse."
Defended or excusedCase context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?
Full statement and sources
Announcing the Safeguarding Women from Chemical Abortion Act, Senator Josh Hawley said the scientific evidence establishes that mifepristone is inherently dangerous to women and open to abuse. His bill would withdraw the drug's federal approval for pregnancy termination, make its distribution and labeling for that purpose violations of the Federal Food, Drug and Cosmetic Act, and allow women who say chemical abortion harmed them to sue its manufacturers.
After the statement
The safety claim rests on a 2025 Ethics and Public Policy Center paper that was not peer reviewed and was criticised by more than 250 reproductive health researchers. The bill was referred to the Senate Health, Education, Labor and Pensions Committee, where it has not moved.
Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders · Josh HawleyOfficial Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.S. 4066 — Safeguarding Women from Chemical Abortion Act, 119th Congress · United States CongressS. 4066, 119th Congress, 2nd Session. Sponsor: Sen. Josh Hawley. Introduced March 11, 2026; referred to the Senate Committee on Health, Education, Labor and Pensions.Why this label?
As the bill's author he advances that proposition directly, grounding it in an asserted safety finding. The closest competing label is “Challenged the characterization”, because the statement is framed as a factual correction to the FDA's assessment of the drug. That loses because the sentence is not confined to disputing a description: it is the stated justification for legislation he simultaneously introduced to enact the ban, which is a substantive endorsement of the conduct under scrutiny rather than a quarrel about labels.
This label describes the statement's response within the context above.
Sources
(24)
Original text
S. 4066 — Safeguarding Women from Chemical Abortion Act, 119th Congress
Relevant passage: S. 4066, 119th Congress, 2nd Session. Sponsor: Sen. Josh Hawley. Introduced March 11, 2026; referred to the Senate Committee on Health, Education, Labor and Pensions.
About this source
The bill at issue in this case. It would withdraw the Food and Drug Administration's approval of mifepristone for pregnancy termination, make distributing and labeling the drug for that purpose violations of the Federal Food, Drug and Cosmetic Act, and create a private right of action for women who say chemical abortion harmed them to sue manufacturers. Legislative status and the cosponsor roster were verified against the GovTrack published record (bill 428713) on September 18, 2026, because congress.gov blocked access: seven Republican cosponsors, none withdrawn, the most recent joining June 23, 2026, and no action beyond committee referral. The identical House companion is H.R. 7902, introduced by Rep. Diana Harshbarger on March 12, 2026.
- Published
- Accessed
Emailed statement
Emailed reply from GenBioPro to Dispute Index declining to comment on Hawley's mifepristone bill
Emailed reply from GenBioPro to Dispute Index declining to comment on Hawley's mifepristone bill
Hi Ben, Reaching out for GenBioPro. At this time, the company prefers not to comment. Thanks, Emma
Full email
Hi Ben, Reaching out for GenBioPro. At this time, the company prefers not to comment. Thanks, Emma
Relevant passage: Emailed reply on behalf of GenBioPro from Feldman Strategies, September 25, 2026 (UTC).
Excerpt
"At this time, the company prefers not to comment."
About this source
Emailed reply sent on behalf of GenBioPro by Emma Thomas of its public relations firm, Feldman Strategies, to a Dispute Index request for the company's response to Sen. Josh Hawley's bill to ban mifepristone. The company declined to comment.
- Author
- Emma Thomas, Feldman Strategies, for GenBioPro
- Published
- Accessed
Reporting
ABC 17 reports responses to Hawley's proposed mifepristone ban
Relevant passage: Wales's direct statement to ABC 17, paragraph 28; Cook-Callen's direct statements to ABC 17, paragraphs 32-37
About this source
Contains statements by Emily Wales, Claire Cook-Callen about abc 17 reports responses to hawley's proposed mifepristone ban.
- Published
- Accessed
Analysis
Josh Hawley explains why Congress should ban mifepristone
Relevant passage: Final policy argument
About this source
Contains statements by Josh Hawley about josh hawley explains why congress should ban mifepristone.
- Author
- Josh Hawley
- Published
- Accessed
Original text
H.R. 7902 as introduced in the House
Relevant passage: Official introduced bill, header and sections 2-3
About this source
Diana Harshbarger introduced H.R. 7902, the House companion proposing to withdraw mifepristone's approval for pregnancy termination and create a federal damages claim.
- Published
- Accessed
Official statement
Janet Morana statement supporting Hawley's mifepristone bill
Relevant passage: Separately attributed Janet Morana statement
About this source
Contains statements by Janet Morana about hawley's mifepristone bill.
- Published
- Accessed
Official statement
Tony Perkins statement supporting the Hawley-Harshbarger bill
Relevant passage: Perkins's original bill-specific statement
About this source
Contains statements by Tony Perkins about the hawley-harshbarger bill.
- Published
- Accessed
Original text
U.S. Repro Watch: Six Updates You Won’t Want to Miss, 3.24.26
Relevant passage: Item 1, "Lawmakers threaten mifepristone"
Excerpt
"Republican Senator Josh Hawley and other lawmakers are urging the FDA to rescind its approval of the abortion pill mifepristone, despite its decades-long safety record."
About this source
News update published on the Center for Reproductive Rights website.
- Published
- Accessed
Reporting
Josh Hawley calls on Congress to ban abortion pill mifepristone
Relevant passage: Paragraphs on Blair Darney, after the passage on advocates and health providers
Excerpt
"The Food and Drug Administration regulates all drugs and devices on the market in the U.S."
About this source
St. Louis Public Radio report, published March 12, 2026, on Senator Josh Hawley's announcement of a bill to withdraw FDA approval of mifepristone, including responses from advocates and health providers.
- Author
- Sarah Fentem
- Published
- Accessed
Official statement
Letter to Congress on the Safeguarding Women from Chemical Abortion Act (April 1, 2026)
Relevant passage: Fifth paragraph and first sentence of the sixth paragraph of the letter, before the closing
Excerpt
"We are very grateful for your leadership in addressing this serious moral issue, and we urge your colleagues in both the House and Senate to support and pass this bill."
About this source
Official letter from the USCCB Committee on Pro-Life Activities to Senator Josh Hawley and Representative Diana Harshbarger, dated April 1, 2026, stating support for S. 4066 and H.R. 7902.
- Author
- Most Reverend Daniel E. Thomas
- Published
- Accessed
Official statement
Statements of Support for the Safeguarding Women from Chemical Abortion Act
Relevant passage: Page 1, statement attributed to Marjorie Dannenfelser, President of SBA Pro-Life America.
Excerpt
"We are thankful to Senator Hawley and Congresswoman Harshbarger for understanding the gravity of this situation"
About this source
Two-page compilation of statements of support for the bill from eight anti-abortion organizations, released by Senator Hawley's office and linked from his March 11, 2026 announcement of the bill.
- Published
- Accessed
Reporting
Amid efforts to restrict mifepristone access, here’s what studies say about the medication
Relevant passage: Third paragraph, on the one-in-ten complication figure.
Excerpt
"it wasn’t published in a peer-reviewed medical journal, and over 250 reproductive health researchers criticized it for methodological issues and its failure to disclose its data source"
About this source
PolitiFact's May 26, 2026 review of the research on mifepristone's safety, written as Republican senators cited a one-in-ten serious-complication figure. It reports where that figure comes from and summarizes the studies on complication rates.
- Author
- Madison Czopek
- Published
- Accessed
Official statement
Tuberville Takes Action to Ban Dangerous Abortion Drug
Relevant passage: Press release dated March 26, 2026, second paragraph (remarks attributed to Tuberville).
Excerpt
"One in ten women who take this drug suffer serious health problems and it needs to be banned."
About this source
Tuberville's own press release announcing that he joined Hawley's bill. It quotes him, lists the bill's three provisions and cites one recent study on complication rates.
- Published
- Accessed
Official statement
Harshbarger, Hawley Introduce Bill to Ban Chemical Abortion Drug
Relevant passage: Press release dated March 12, 2026, second paragraph (remarks attributed to Harshbarger).
Excerpt
"I believe every drug approved in the United States must meet the highest standards of safety, transparency, and medical oversight"
About this source
Harshbarger's own press release announcing the House companion to Hawley's bill. It quotes both lawmakers, lists the bill's three provisions and names eight supporting organizations.
- Published
- Accessed
Reporting
Trump's FDA pick Heidi Overton calls vaccines, mifepristone safe and effective in confirmation hearing
Relevant passage: Paragraphs beginning "Senator Josh Hawley" and "In court, Hawley said."
Excerpt
"Senator Josh Hawley later challenged Overton's response, claiming, "that's not the FDA's position in court.""
About this source
Fierce Biotech reported on the September 24 Senate HELP Committee hearing for FDA commissioner nominee Heidi Overton. The report says Hawley challenged Overton over mifepristone regulation and the FDA's position in ongoing litigation.
- Author
- Darren Incorvaia and Marissa Russo
- Published
- Accessed
Reporting
Overton skirts senators' questions on abortion pill
Relevant passage: Paragraph beginning "Missouri Republican Josh Hawley" and the article's report of the Senate HELP Committee hearing.
Excerpt
"Missouri Republican Josh Hawley, who staunchly opposes abortion, argued during the hearing that Overton's position on mifepristone clashes with the position the Trump administration has asserted in court battles over federal regulation of the medication."
About this source
Politico reported on the September 24 Senate HELP Committee hearing for FDA commissioner nominee Heidi Overton. Its report describes Hawley challenging Overton about mifepristone regulation and the administration's position in court.
- Author
- Lauren Gardner, Alice Miranda Ollstein and Robert King
- Published
- Accessed
Interview
EXCLUSIVE: Sen. Hawley says FDA commissioner nominee denied dangers of chemical abortion; demands answers amid lawsuits, official review
Relevant passage: Paragraphs beginning "What I want to be real sure about" and "We've got to make sure."
Excerpt
"We've got to make sure that she is committed to ending the abortion drugs' availability in the state of Missouri and every other state. That they're going to put back in place the safety restrictions and they're going to follow the law."
About this source
Heartlander News identifies the remarks as a post-hearing interview with Hawley after Heidi Overton's September 24 Senate HELP Committee confirmation hearing. The article quotes Hawley calling for the FDA under Overton to end abortion-drug availability in Missouri and every other state and to restore safety restrictions.
- Author
- Michaela Estruth
- Published
- Accessed
Official statement
Senate Introduces Attack on Mifepristone
Relevant passage: Organizational press release, March 12, 2026, carrying a statement attributed to president and chief executive Dr. Jamila Perritt.
Excerpt
"the science is clear: mifepristone is safe, mifepristone is effective, and mifepristone is still medically indicated"
About this source
The response from a national physicians' organization, answering Hawley's safety claim on clinical grounds. Perritt's phrasing deliberately mirrors Hawley's own "the science is clear" formulation from the bill announcement.
- Published
- Accessed
Official statement
Reproductive Freedom for All Condemns Senator Hawley's Bill To Revoke FDA Approval of Mifepristone
Relevant passage: Organizational press release, March 12, 2026, carrying a statement attributed to president and chief executive Mini Timmaraju.
Excerpt
"Let's not forget: Senator Hawley's own constituents voted to protect abortion access. But he and his extremist colleagues will not stop until they've banned abortion nationwide."
About this source
The organization's official response to the bill, notable for grounding its objection in the 2024 Missouri ballot measure protecting abortion access in Hawley's own state.
- Published
- Accessed
Reporting
Anti-abortion groups to GOP: Act on mifepristone or pay in the midterms
Relevant passage: MS NOW, March 13, 2026. Report on the Republican and anti-abortion movement response to the Hawley bill.
Excerpt
"When asked, Sen. Bill Cassidy, R-La., chairman of the Health, Education, Labor and Pensions Committee, told MS NOW on Thursday he opposes the current scope of availability of abortion pills — before adding, "I haven't seen this particular legislation.""
About this source
Source for Bill Cassidy's response as chairman of the committee holding the bill, John Cornyn's "All in" post on X, Chuck Schumer's reaction, and Alexis McGill Johnson's statement. Also records that spokespeople for Susan Collins and Lisa Murkowski did not respond to questions about the bill, and that the two were the only Republican senators who declined to sign a letter to the Department of Health and Human Services calling for a mifepristone crackdown.
- Published
- Accessed
Reporting
Hawley's abortion pill move puts Republican senators in a bind
Relevant passage: Axios, March 19, 2026. Report on Senate Republican reaction to the Safeguarding Women from Chemical Abortion Act.
Excerpt
"Sen. Jon Husted (R-Ohio), who faces a competitive reelection race, told Axios he hasn't seen Hawley's bill when asked for his position on it. Sen. Thom Tillis (R-N.C.) likewise said he had not seen the bill."
About this source
The fullest available account of Senate Republican reluctance on the bill, with direct responses from Husted and Tillis, Hawley's reply to Axios, and Marjorie Dannenfelser's criticism of the Trump administration's handling of mifepristone litigation.
- Author
- Peter Sullivan
- Published
- Accessed
Reporting
Hawley to push GOP officeholders, candidates to sign 'Declaration for Life'
Relevant passage: The Hill, September 16, 2026, 12:15 PM ET. Report on the Declaration for Life unveiling.
Excerpt
"Hawley's mifepristone bill has at least seven Republican co-sponsors but hasn't received much discussion within the Senate GOP conference since he introduced it."
About this source
Contemporaneous reporting on the September 16 event, naming Tony Perkins of the Family Research Council and the Christian musician Sean Feucht as joining Hawley at the unveiling, and recording Hawley's request that candidates in both parties sign the pledge. The same quotations appear in the syndicated version carried by Yahoo News.
- Author
- Alexander Bolton
- Published
- Accessed
Official statement
Hawley Unveils Declaration for Life with Christian Leaders
Relevant passage: Official Senate office press release following the first Missouri Prayer Breakfast, held September 16, 2026, in the Kennedy Caucus Room of the Russell Senate Office Building. Includes the text of the four-page Declaration for Life.
Excerpt
"This Declaration for Life, written by pastors, is calling on everyday Christians across America to stand for life and confront the scourge of chemical abortion."
About this source
The primary record of the Declaration for Life, the pledge Hawley is asking officeholders and candidates to sign. The declaration states that the abortion drug is "nearly always fatal to the unborn child and frequently injurious to the mother," that mifepristone "can now be mailed into every state and city in America, regardless of local rules," and calls on Congress "to ban the chemical abortion drug mifepristone."
- Author
- Office of Senator Josh Hawley
- Published
- Accessed
Official statement
Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders
Relevant passage: Official Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.
Excerpt
"The science is clear: the chemical abortion drug is inherently dangerous to women and prone to abuse."
About this source
Hawley's own announcement of the bill, issued alongside a Capitol Hill press conference with anti-abortion movement leaders. It states the bill's three operative provisions and carries the quotation on which his safety claim rests.
- Author
- Office of Senator Josh Hawley
- Published
- Accessed
Share or embed this case
The embed keeps its attribution link to The Dispute Index. Credit the image to The Dispute Index and link to the case page.
Cite this record
- Publisher
- The Dispute Index
- Title
- Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?
- First published
- Last updated
- Permalink
- https://disputeindex.com/cases/congress-ban-abortion-pill-mifepristone-hawley
The Dispute Index. "Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?". First published: 2026-09-18. Last updated: 2026-09-26. https://disputeindex.com/cases/congress-ban-abortion-pill-mifepristone-hawley